001 SER+20150128094254
100 ^a20150128d2010 k y0porb0103 ba
101 0 ^aeng
102 ^aZA
200 1 ^aThe SAPIT trial provides essential evidence on risks and benefits of integrated and sequential treatment of HIV and tuberculosis^fQuarraisha Abdool Karim...[et al.]
461 1^tSouth African Medical Journal (SAMJ)^cCidade do Cabo^bHealth and Medical Publishing Group^d2010^vvol. 100, nº 12^ppp. 808-809^x0256-9574
606 ^aDoente seropositivo^2SER+
606 ^aTuberculose^2SER+
606 ^aTratamento anti retrovírico^2SER+
606 ^aEnsaios clínicos^2SER+
606 ^aSAPIT trial
700 1^aKarim, ^bQuarraisha Abdool
701 1^aKarim,^bSalim S. Abdool^4070
701 1^aBaxter, ^bCheryl ^4070
701 1^aFriedland, ^bGerald ^4070
701 1^aGengiah,^bTanuja^4070
701 1^aGray,^bAndrew^4070
701 1^aGrobler,^bAnneke^4070
701 1^aNaidoo, ^bKogieleum^4070
701 1^aPadayatchi,^bNesri ^4070
701 1^aEl-Sadr,^bWafaa ^4070
856 ^u/BiblioNET/Upload/PDF8/006452_SAMJ 0113_v100n12a15.pdf^zTexto em PDF
920 n
921 a
922 a
931 20150128
932 d
933 2010
935 k
936 y
937 0
938 ba